Evaluation of differing taxanes/taxane combinations on the outcomes of patients with operable breast cancer
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Capecitabine; Cyclophosphamide; Docetaxel; Epirubicin; Fluorouracil; Paclitaxel
- Indications Breast cancer
- Focus Therapeutic Use
- 29 Aug 2011 Biomarkers information updated
- 25 Aug 2011 Actual end date (Aug 2011) added as reported by ClinicalTrials.gov.
- 25 Aug 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.